![UBS lifts its 2025 gold price forecast. Here's the new target](https://i-invdn-com.investing.com/news/LYNXNPEB8N174_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.410 | 1.590 | 0.180 |
Stocks | 98.600 | 98.600 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.574 | 18.164 |
Price to Book | 4.034 | 3.695 |
Price to Sales | 4.732 | 5.353 |
Price to Cash Flow | 12.591 | 13.633 |
Dividend Yield | 0.863 | 0.516 |
5 Years Earnings Growth | 7.324 | 19.708 |
Number of long holdings: 98
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 10.81 | 104.08 | -1.77% | |
Amgen | US0311621009 | 8.12 | 291.16 | -1.96% | |
Vertex | US92532F1003 | 7.74 | 459.00 | -0.77% | |
Regeneron Pharma | US75886F1075 | 4.41 | 673.60 | -0.10% | |
Alnylam | US02043Q1076 | 3.29 | 256.45 | -3.19% | |
AstraZeneca ADR | US0463531089 | 3.14 | 73.58 | -1.17% | |
Insmed | US4576693075 | 2.99 | 79.31 | +0.81% | |
Illumina | US4523271090 | 2.20 | 100.24 | -1.51% | |
argenx ADR | US04016X1019 | 2.16 | 639.41 | -1.83% | |
Neurocrine | US64125C1099 | 2.00 | 115.02 | -1.58% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Kapital Plus A EUR | 2.81B | 0.40 | -2.67 | 2.01 | ||
Kapital Plus P2 EUR | 2.65M | 1.06 | -2.02 | 2.69 | ||
Kapital Plus I EUR | 100.2M | 0.91 | -2.17 | 2.54 | ||
Kapital Plus P EUR | 7.77M | 0.91 | -2.17 | 2.49 | ||
DE000A2DU1Y2 | 18.45M | -0.15 | -3.20 | 1.46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review